These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 15377178)
1. Detection of anti-D following antepartum injections of Rh immune globulin. Kennedy MS; McNanie J; Waheed A Immunohematology; 1998; 14(4):138-40. PubMed ID: 15377178 [TBL] [Abstract][Full Text] [Related]
2. Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin. Rushin J; Rumsey DH; Ewing CA; Sandler SG Transfusion; 2000 May; 40(5):551-4. PubMed ID: 10827257 [TBL] [Abstract][Full Text] [Related]
3. The routine use of Rh-negative reagent red cells for the identification of anti-D and the detection of non-D red cell antibodies. Shulman IA; Calderon C; Nelson JM; Nakayama R Transfusion; 1994 Aug; 34(8):666-70. PubMed ID: 8073481 [TBL] [Abstract][Full Text] [Related]
4. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy. Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749 [TBL] [Abstract][Full Text] [Related]
5. Immunoprophylaxis using intravenous Rh immune globulin should be standard practice when selected D-negative patients are transfused with D-positive random donor platelets. Ewing CA; Rumsey DH; Langberg AF; Sandler SG Immunohematology; 1998; 14(4):133-7. PubMed ID: 15377177 [TBL] [Abstract][Full Text] [Related]
6. Pathology Consultation on Patients With a Large Rh Immune Globulin Dose Requirement. Welsh KJ; Bai Y; Am J Clin Pathol; 2016 Jun; 145(6):744-51. PubMed ID: 27267375 [TBL] [Abstract][Full Text] [Related]
7. Intravenous Rh immune globulin prevents alloimmunization in D- granulocyte recipients but obscures the detection of an allo-anti-K. Stroncek DF; Procter JL; Moses L; Bolan C; Pomper GJ; Conroy-Cantilena C; Malech HL; Klein HG; Leitman SF Immunohematology; 2001; 17(2):37-41. PubMed ID: 15373589 [TBL] [Abstract][Full Text] [Related]
8. Management and Follow-up of Massive Fetomaternal Hemorrhage Requiring High-Dose Rh Immune Globulin: A Case Report. Fortes PA; Gnass ED; Baez J; Bayati B; Mei Z; McGonigle AM; Ziman A; Ward DC Am J Clin Pathol; 2023 Jul; 160(1):78-80. PubMed ID: 36897771 [TBL] [Abstract][Full Text] [Related]
9. Antenatal administration of Rh-immune globulin causes significant increases in the immunomodulatory cytokines transforming growth factor-beta and prostaglandin E2. Branch DR; Shabani F; Lund N; Denomme GA Transfusion; 2006 Aug; 46(8):1316-22. PubMed ID: 16934066 [TBL] [Abstract][Full Text] [Related]
18. Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin. Branch DR; Scofield TL; Moulds JJ; Swanson JL Transfusion; 2011 Apr; 51(4):816-9. PubMed ID: 20946183 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of different testing methods for identification of RhIG in red blood cell antibody detection. Mikesell KV; George MR; Castellani WJ; Domen RE; Gould JM; Davis JW; Herman JH Transfusion; 2015 Jun; 55(6 Pt 2):1444-50. PubMed ID: 25648788 [TBL] [Abstract][Full Text] [Related]
20. Elevated anti-D titer after the administration of Rh immune globulin. A case report. Andres RL; Branch DW; Scott JR J Reprod Med; 1989 Apr; 34(4):318-20. PubMed ID: 2497253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]